Relmada Therapeutics, Inc. (RLMD) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for RLMD

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Relmada Therapeutics, Inc. a strong or weak investment candidate.

▲ Valuation

Is RLMD priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and RLMD's own history. Our valuation engine flags whether Relmada Therapeutics, Inc. is trading rich, fair, or cheap.

▲ Profitability

How efficient is Relmada Therapeutics, Inc.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can RLMD survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Relmada Therapeutics, Inc.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's RLMD earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Relmada Therapeutics, Inc.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Relmada Therapeutics, Inc. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete RLMD breakdown

Sign up free to unlock Relmada Therapeutics, Inc.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about RLMD

Quick answers to the most common questions about Relmada Therapeutics, Inc..

What does Relmada Therapeutics, Inc. (RLMD) do?

Relmada Therapeutics, Inc. is a publicly traded company under the ticker symbol RLMD. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze RLMD stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including RLMD. Each pillar uses standardized metrics that let you compare Relmada Therapeutics, Inc. to its peers and to its own history.

Is RLMD a good stock to buy?

Whether Relmada Therapeutics, Inc. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see RLMD's financial data?

Sign up free at TopTier Strategy to access Relmada Therapeutics, Inc.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Relmada Therapeutics, Inc. (RLMD)